APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Disodium for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pemetrexed Disodium for Injection Industry Growth and Trends Forecast to 2032

Report ID 174023250122 December 2025127 pages

Choose your research edition.

Industry ResearchPemetrexed Disodium for Injection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Disodium for Injection Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Pemetrexed Disodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Disodium for Injection Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Disodium for Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Pemetrexed Disodium for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pemetrexed Disodium for Injection include Accord Healthcare, Amneal Pharmaceuticals, APOTEX, Biocon, Dr. Reddy's Laboratories, Eugia Pharma, Nang Kuang Pharmaceutical, Pfizer (Hospira) and Waverley Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pemetrexed Disodium for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pemetrexed Disodium for Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pemetrexed Disodium for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pemetrexed Disodium for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pemetrexed Disodium for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pemetrexed Disodium for Injection Market by Company

Accord Healthcare

Amneal Pharmaceuticals

APOTEX

Biocon

Dr. Reddy's Laboratories

Eugia Pharma

Nang Kuang Pharmaceutical

Pfizer (Hospira)

Waverley Pharma

Zydus Lifesciences

Baxter

Beijing Xiehe Pharmaceutical

Dezhou Deyao Pharmaceutical

Fresenius Kabi

Hainan Jinrui Pharmaceutical

Kelun Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Lilly

Lianyungang Jaripharm Pharmaceutical

Nanjing Pharmaceutical Factory

Jiangsu Hansoh Pharmaceutical

Sandoz

Zhendong Group

Shanghai Chemo Wanbang Biopharma

Sichuan Huiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Suzhou Thery Pharmaceutical

Jiangsu Simcere Pharmaceutical

Yangtze River Pharmaceutical Group

Pemetrexed Disodium for Injection Segment by Type

500mg/Pcs

100mg/Pcs

Pemetrexed Disodium for Injection Segment by Application

Hospitals

Clinics

Others

Pemetrexed Disodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pemetrexed Disodium for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pemetrexed Disodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500mg/Pcs Table 2. Major Company of 100mg/Pcs Table 3. Global Pemetrexed Disodium for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 5. Global Pemetrexed Disodium for Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pemetrexed Disodium for Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Pemetrexed Disodium for Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 10. Global Pemetrexed Disodium for Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pemetrexed Disodium for Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Pemetrexed Disodium for Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 15. North America Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Pemetrexed Disodium for Injection Industry Trends Table 25. Pemetrexed Disodium for Injection Industry Drivers Table 26. Pemetrexed Disodium for Injection Industry Opportunities and Challenges Table 27. Pemetrexed Disodium for Injection Industry Restraints Table 28. Global Pemetrexed Disodium for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pemetrexed Disodium for Injection Revenue Market Share by Company (2021-2026) Table 30. Global Pemetrexed Disodium for Injection Sales by Company (2021-2026) & (k units) Table 31. Global Pemetrexed Disodium for Injection Sales Share by Company (2021-2026) Table 32. Global Pemetrexed Disodium for Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Pemetrexed Disodium for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pemetrexed Disodium for Injection Major Company Production Sites and Headquarters Table 35. Global Pemetrexed Disodium for Injection Company, Product Type & Application Table 36. Global Pemetrexed Disodium for Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pemetrexed Disodium for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pemetrexed Disodium for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pemetrexed Disodium for Injection Sales by Region (2021-2026) & (k units) Table 41. Global Pemetrexed Disodium for Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pemetrexed Disodium for Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pemetrexed Disodium for Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Pemetrexed Disodium for Injection Sales by Region (2027-2032) & (k units) Table 46. Global Pemetrexed Disodium for Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pemetrexed Disodium for Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pemetrexed Disodium for Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Pemetrexed Disodium for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 52. Global Pemetrexed Disodium for Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pemetrexed Disodium for Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Pemetrexed Disodium for Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 57. Global Pemetrexed Disodium for Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pemetrexed Disodium for Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Pemetrexed Disodium for Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 62. North America Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Accord Healthcare Company Information Table 72. Accord Healthcare Business Overview Table 73. Accord Healthcare Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio Table 75. Accord Healthcare Recent Development Table 76. Amneal Pharmaceuticals Company Information Table 77. Amneal Pharmaceuticals Business Overview Table 78. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio Table 80. Amneal Pharmaceuticals Recent Development Table 81. APOTEX Company Information Table 82. APOTEX Business Overview Table 83. APOTEX Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. APOTEX Pemetrexed Disodium for Injection Product Portfolio Table 85. APOTEX Recent Development Table 86. Biocon Company Information Table 87. Biocon Business Overview Table 88. Biocon Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Biocon Pemetrexed Disodium for Injection Product Portfolio Table 90. Biocon Recent Development Table 91. Dr. Reddy's Laboratories Company Information Table 92. Dr. Reddy's Laboratories Business Overview Table 93. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio Table 95. Dr. Reddy's Laboratories Recent Development Table 96. Eugia Pharma Company Information Table 97. Eugia Pharma Business Overview Table 98. Eugia Pharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio Table 100. Eugia Pharma Recent Development Table 101. Nang Kuang Pharmaceutical Company Information Table 102. Nang Kuang Pharmaceutical Business Overview Table 103. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 105. Nang Kuang Pharmaceutical Recent Development Table 106. Pfizer (Hospira) Company Information Table 107. Pfizer (Hospira) Business Overview Table 108. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio Table 110. Pfizer (Hospira) Recent Development Table 111. Waverley Pharma Company Information Table 112. Waverley Pharma Business Overview Table 113. Waverley Pharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio Table 115. Waverley Pharma Recent Development Table 116. Zydus Lifesciences Company Information Table 117. Zydus Lifesciences Business Overview Table 118. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio Table 120. Zydus Lifesciences Recent Development Table 121. Baxter Company Information Table 122. Baxter Business Overview Table 123. Baxter Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Baxter Pemetrexed Disodium for Injection Product Portfolio Table 125. Baxter Recent Development Table 126. Beijing Xiehe Pharmaceutical Company Information Table 127. Beijing Xiehe Pharmaceutical Business Overview Table 128. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 130. Beijing Xiehe Pharmaceutical Recent Development Table 131. Dezhou Deyao Pharmaceutical Company Information Table 132. Dezhou Deyao Pharmaceutical Business Overview Table 133. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 135. Dezhou Deyao Pharmaceutical Recent Development Table 136. Fresenius Kabi Company Information Table 137. Fresenius Kabi Business Overview Table 138. Fresenius Kabi Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio Table 140. Fresenius Kabi Recent Development Table 141. Hainan Jinrui Pharmaceutical Company Information Table 142. Hainan Jinrui Pharmaceutical Business Overview Table 143. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 145. Hainan Jinrui Pharmaceutical Recent Development Table 146. Kelun Pharmaceutical Company Information Table 147. Kelun Pharmaceutical Business Overview Table 148. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 150. Kelun Pharmaceutical Recent Development Table 151. Jiangsu Aosaikang Pharmaceutical Company Information Table 152. Jiangsu Aosaikang Pharmaceutical Business Overview Table 153. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 155. Jiangsu Aosaikang Pharmaceutical Recent Development Table 156. Qilu Pharmaceutical Company Information Table 157. Qilu Pharmaceutical Business Overview Table 158. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 160. Qilu Pharmaceutical Recent Development Table 161. Lilly Company Information Table 162. Lilly Business Overview Table 163. Lilly Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Lilly Pemetrexed Disodium for Injection Product Portfolio Table 165. Lilly Recent Development Table 166. Lianyungang Jaripharm Pharmaceutical Company Information Table 167. Lianyungang Jaripharm Pharmaceutical Business Overview Table 168. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 170. Lianyungang Jaripharm Pharmaceutical Recent Development Table 171. Nanjing Pharmaceutical Factory Company Information Table 172. Nanjing Pharmaceutical Factory Business Overview Table 173. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 174. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio Table 175. Nanjing Pharmaceutical Factory Recent Development Table 176. Jiangsu Hansoh Pharmaceutical Company Information Table 177. Jiangsu Hansoh Pharmaceutical Business Overview Table 178. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 179. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 180. Jiangsu Hansoh Pharmaceutical Recent Development Table 181. Sandoz Company Information Table 182. Sandoz Business Overview Table 183. Sandoz Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 184. Sandoz Pemetrexed Disodium for Injection Product Portfolio Table 185. Sandoz Recent Development Table 186. Zhendong Group Company Information Table 187. Zhendong Group Business Overview Table 188. Zhendong Group Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 189. Zhendong Group Pemetrexed Disodium for Injection Product Portfolio Table 190. Zhendong Group Recent Development Table 191. Shanghai Chemo Wanbang Biopharma Company Information Table 192. Shanghai Chemo Wanbang Biopharma Business Overview Table 193. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 194. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio Table 195. Shanghai Chemo Wanbang Biopharma Recent Development Table 196. Sichuan Huiyu Pharmaceutical Company Information Table 197. Sichuan Huiyu Pharmaceutical Business Overview Table 198. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 199. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 200. Sichuan Huiyu Pharmaceutical Recent Development Table 201. Suzhou Erye Pharmaceutical Company Information Table 202. Suzhou Erye Pharmaceutical Business Overview Table 203. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 204. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 205. Suzhou Erye Pharmaceutical Recent Development Table 206. Suzhou Thery Pharmaceutical Company Information Table 207. Suzhou Thery Pharmaceutical Business Overview Table 208. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 209. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 210. Suzhou Thery Pharmaceutical Recent Development Table 211. Jiangsu Simcere Pharmaceutical Company Information Table 212. Jiangsu Simcere Pharmaceutical Business Overview Table 213. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 214. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 215. Jiangsu Simcere Pharmaceutical Recent Development Table 216. Yangtze River Pharmaceutical Group Company Information Table 217. Yangtze River Pharmaceutical Group Business Overview Table 218. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 219. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio Table 220. Yangtze River Pharmaceutical Group Recent Development Table 221. North America Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 222. North America Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 223. North America Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2026) Table 224. North America Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032) & (k units) Table 225. North America Pemetrexed Disodium for Injection Sales Market Share Forecast by Country (2027-2032) Table 226. North America Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. North America Pemetrexed Disodium for Injection Market Size by Country (2021-2026) & (US$ Million) Table 228. North America Pemetrexed Disodium for Injection Market Share by Country (2021-2026) Table 229. North America Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. North America Pemetrexed Disodium for Injection Market Share Forecast by Country (2027-2032) Table 231. Europe Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 232. Europe Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 233. Europe Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2026) Table 234. Europe Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032) & (k units) Table 235. Europe Pemetrexed Disodium for Injection Sales Market Share Forecast by Country (2027-2032) Table 236. Europe Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Europe Pemetrexed Disodium for Injection Market Size by Country (2021-2026) & (US$ Million) Table 238. Europe Pemetrexed Disodium for Injection Market Share by Country (2021-2026) Table 239. Europe Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Europe Pemetrexed Disodium for Injection Market Share Forecast by Country (2027-2032) Table 241. Asia-Pacific Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 242. Asia-Pacific Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 243. Asia-Pacific Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2026) Table 244. Asia-Pacific Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032) & (k units) Table 245. Asia-Pacific Pemetrexed Disodium for Injection Sales Market Share Forecast by Country (2027-2032) Table 246. Asia-Pacific Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 247. Asia-Pacific Pemetrexed Disodium for Injection Market Size by Country (2021-2026) & (US$ Million) Table 248. Asia-Pacific Pemetrexed Disodium for Injection Market Share by Country (2021-2026) Table 249. Asia-Pacific Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 250. Asia-Pacific Pemetrexed Disodium for Injection Market Share Forecast by Country (2027-2032) Table 251. Latin America Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 252. Latin America Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 253. Latin America Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2026) Table 254. Latin America Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032) & (k units) Table 255. Latin America Pemetrexed Disodium for Injection Sales Market Share Forecast by Country (2027-2032) Table 256. Latin America Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 257. Latin America Pemetrexed Disodium for Injection Market Size by Country (2021-2026) & (US$ Million) Table 258. Latin America Pemetrexed Disodium for Injection Market Share by Country (2021-2026) Table 259. Latin America Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 260. Latin America Pemetrexed Disodium for Injection Market Share Forecast by Country (2027-2032) Table 261. Middle East and Africa Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 262. Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 263. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2026) Table 264. Middle East and Africa Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032) & (k units) Table 265. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share Forecast by Country (2027-2032) Table 266. Middle East and Africa Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 267. Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country (2021-2026) & (US$ Million) Table 268. Middle East and Africa Pemetrexed Disodium for Injection Market Share by Country (2021-2026) Table 269. Middle East and Africa Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 270. Middle East and Africa Pemetrexed Disodium for Injection Market Share Forecast by Country (2027-2032) Table 271. Key Raw Materials Table 272. Raw Materials Key Suppliers Table 273. Pemetrexed Disodium for Injection Distributors List Table 274. Pemetrexed Disodium for Injection Customers List Table 275. Research Programs/Design for This Report Table 276. Authors List of This Report Table 277. Secondary Sources Table 278. Primary Sources List of Figures Figure 1. Pemetrexed Disodium for Injection Image Figure 2. Global Pemetrexed Disodium for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Disodium for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Disodium for Injection Sales (2021-2032) & (k units) Figure 5. 500mg/Pcs Image Figure 6. Global 500mg/Pcs Sales YoY Growth (2021-2032) & (k units) Figure 7. 100mg/Pcs Image Figure 8. Global 100mg/Pcs Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Pemetrexed Disodium for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pemetrexed Disodium for Injection Market Share by Type 2025 VS 2032 Figure 11. North America Pemetrexed Disodium for Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Pemetrexed Disodium for Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Pemetrexed Disodium for Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pemetrexed Disodium for Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pemetrexed Disodium for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pemetrexed Disodium for Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pemetrexed Disodium for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pemetrexed Disodium for Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pemetrexed Disodium for Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Pemetrexed Disodium for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pemetrexed Disodium for Injection Market Share by Application 2025 VS 2032 Figure 31. North America Pemetrexed Disodium for Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Pemetrexed Disodium for Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Pemetrexed Disodium for Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pemetrexed Disodium for Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pemetrexed Disodium for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pemetrexed Disodium for Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pemetrexed Disodium for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pemetrexed Disodium for Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Pemetrexed Disodium for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pemetrexed Disodium for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Pemetrexed Disodium for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pemetrexed Disodium for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Pemetrexed Disodium for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pemetrexed Disodium for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Pemetrexed Disodium for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pemetrexed Disodium for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Pemetrexed Disodium for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pemetrexed Disodium for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pemetrexed Disodium for Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pemetrexed Disodium for Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg/Pcs
  • 100mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Accord Healthcare
  • Amneal Pharmaceuticals
  • APOTEX
  • Biocon
  • Dr. Reddy's Laboratories
  • Eugia Pharma
  • Nang Kuang Pharmaceutical
  • Pfizer (Hospira)
  • Waverley Pharma
  • Zydus Lifesciences
  • Baxter
  • Beijing Xiehe Pharmaceutical
  • Dezhou Deyao Pharmaceutical
  • Fresenius Kabi
  • Hainan Jinrui Pharmaceutical
  • Kelun Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Lilly
  • Lianyungang Jaripharm Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Jiangsu Hansoh Pharmaceutical
  • Sandoz
  • Zhendong Group
  • Shanghai Chemo Wanbang Biopharma
  • Sichuan Huiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Suzhou Thery Pharmaceutical
  • Jiangsu Simcere Pharmaceutical
  • Yangtze River Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pemetrexed Disodium for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pemetrexed Disodium for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pemetrexed Disodium for Injection Market by Type
  6. 1.3.1 500mg/Pcs
  7. 1.3.2 100mg/Pcs
  8. 1.4 Global Pemetrexed Disodium for Injection Market Size by Type
  9. 1.4.1 Global Pemetrexed Disodium for Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pemetrexed Disodium for Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pemetrexed Disodium for Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pemetrexed Disodium for Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pemetrexed Disodium for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pemetrexed Disodium for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pemetrexed Disodium for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pemetrexed Disodium for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pemetrexed Disodium for Injection Industry Trends
  2. 2.2 Pemetrexed Disodium for Injection Industry Drivers
  3. 2.3 Pemetrexed Disodium for Injection Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Disodium for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pemetrexed Disodium for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Pemetrexed Disodium for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Pemetrexed Disodium for Injection Price (2021-2026)
  4. 3.4 Global Pemetrexed Disodium for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pemetrexed Disodium for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Pemetrexed Disodium for Injection Company, Product Type & Application
  7. 3.7 Global Pemetrexed Disodium for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pemetrexed Disodium for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pemetrexed Disodium for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pemetrexed Disodium for Injection Tier 1, Tier 2, and Tier 3
4 Pemetrexed Disodium for Injection Regional Status and Outlook
  1. 4.1 Global Pemetrexed Disodium for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pemetrexed Disodium for Injection Historic Market Size by Region
  3. 4.2.1 Global Pemetrexed Disodium for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pemetrexed Disodium for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pemetrexed Disodium for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pemetrexed Disodium for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Pemetrexed Disodium for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pemetrexed Disodium for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pemetrexed Disodium for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pemetrexed Disodium for Injection by Application
  1. 5.1 Pemetrexed Disodium for Injection Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Disodium for Injection Market Size by Application
  6. 5.2.1 Global Pemetrexed Disodium for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pemetrexed Disodium for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pemetrexed Disodium for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pemetrexed Disodium for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pemetrexed Disodium for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pemetrexed Disodium for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pemetrexed Disodium for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pemetrexed Disodium for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Accord Healthcare
  2. 6.1.1 Accord Healthcare Company Information
  3. 6.1.2 Accord Healthcare Business Overview
  4. 6.1.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
  6. 6.1.5 Accord Healthcare Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 APOTEX
  14. 6.3.1 APOTEX Company Information
  15. 6.3.2 APOTEX Business Overview
  16. 6.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 APOTEX Pemetrexed Disodium for Injection Product Portfolio
  18. 6.3.5 APOTEX Recent Developments
  19. 6.4 Biocon
  20. 6.4.1 Biocon Company Information
  21. 6.4.2 Biocon Business Overview
  22. 6.4.3 Biocon Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biocon Pemetrexed Disodium for Injection Product Portfolio
  24. 6.4.5 Biocon Recent Developments
  25. 6.5 Dr. Reddy's Laboratories
  26. 6.5.1 Dr. Reddy's Laboratories Company Information
  27. 6.5.2 Dr. Reddy's Laboratories Business Overview
  28. 6.5.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
  30. 6.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 6.6 Eugia Pharma
  32. 6.6.1 Eugia Pharma Company Information
  33. 6.6.2 Eugia Pharma Business Overview
  34. 6.6.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
  36. 6.6.5 Eugia Pharma Recent Developments
  37. 6.7 Nang Kuang Pharmaceutical
  38. 6.7.1 Nang Kuang Pharmaceutical Company Information
  39. 6.7.2 Nang Kuang Pharmaceutical Business Overview
  40. 6.7.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  42. 6.7.5 Nang Kuang Pharmaceutical Recent Developments
  43. 6.8 Pfizer (Hospira)
  44. 6.8.1 Pfizer (Hospira) Company Information
  45. 6.8.2 Pfizer (Hospira) Business Overview
  46. 6.8.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
  48. 6.8.5 Pfizer (Hospira) Recent Developments
  49. 6.9 Waverley Pharma
  50. 6.9.1 Waverley Pharma Company Information
  51. 6.9.2 Waverley Pharma Business Overview
  52. 6.9.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
  54. 6.9.5 Waverley Pharma Recent Developments
  55. 6.10 Zydus Lifesciences
  56. 6.10.1 Zydus Lifesciences Company Information
  57. 6.10.2 Zydus Lifesciences Business Overview
  58. 6.10.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
  60. 6.10.5 Zydus Lifesciences Recent Developments
  61. 6.11 Baxter
  62. 6.11.1 Baxter Company Information
  63. 6.11.2 Baxter Business Overview
  64. 6.11.3 Baxter Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Baxter Pemetrexed Disodium for Injection Product Portfolio
  66. 6.11.5 Baxter Recent Developments
  67. 6.12 Beijing Xiehe Pharmaceutical
  68. 6.12.1 Beijing Xiehe Pharmaceutical Company Information
  69. 6.12.2 Beijing Xiehe Pharmaceutical Business Overview
  70. 6.12.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  72. 6.12.5 Beijing Xiehe Pharmaceutical Recent Developments
  73. 6.13 Dezhou Deyao Pharmaceutical
  74. 6.13.1 Dezhou Deyao Pharmaceutical Company Information
  75. 6.13.2 Dezhou Deyao Pharmaceutical Business Overview
  76. 6.13.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  78. 6.13.5 Dezhou Deyao Pharmaceutical Recent Developments
  79. 6.14 Fresenius Kabi
  80. 6.14.1 Fresenius Kabi Company Information
  81. 6.14.2 Fresenius Kabi Business Overview
  82. 6.14.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
  84. 6.14.5 Fresenius Kabi Recent Developments
  85. 6.15 Hainan Jinrui Pharmaceutical
  86. 6.15.1 Hainan Jinrui Pharmaceutical Company Information
  87. 6.15.2 Hainan Jinrui Pharmaceutical Business Overview
  88. 6.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  90. 6.15.5 Hainan Jinrui Pharmaceutical Recent Developments
  91. 6.16 Kelun Pharmaceutical
  92. 6.16.1 Kelun Pharmaceutical Company Information
  93. 6.16.2 Kelun Pharmaceutical Business Overview
  94. 6.16.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  96. 6.16.5 Kelun Pharmaceutical Recent Developments
  97. 6.17 Jiangsu Aosaikang Pharmaceutical
  98. 6.17.1 Jiangsu Aosaikang Pharmaceutical Company Information
  99. 6.17.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  100. 6.17.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  102. 6.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  103. 6.18 Qilu Pharmaceutical
  104. 6.18.1 Qilu Pharmaceutical Company Information
  105. 6.18.2 Qilu Pharmaceutical Business Overview
  106. 6.18.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  108. 6.18.5 Qilu Pharmaceutical Recent Developments
  109. 6.19 Lilly
  110. 6.19.1 Lilly Company Information
  111. 6.19.2 Lilly Business Overview
  112. 6.19.3 Lilly Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Lilly Pemetrexed Disodium for Injection Product Portfolio
  114. 6.19.5 Lilly Recent Developments
  115. 6.20 Lianyungang Jaripharm Pharmaceutical
  116. 6.20.1 Lianyungang Jaripharm Pharmaceutical Company Information
  117. 6.20.2 Lianyungang Jaripharm Pharmaceutical Business Overview
  118. 6.20.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  120. 6.20.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
  121. 6.21 Nanjing Pharmaceutical Factory
  122. 6.21.1 Nanjing Pharmaceutical Factory Company Information
  123. 6.21.2 Nanjing Pharmaceutical Factory Business Overview
  124. 6.21.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
  126. 6.21.5 Nanjing Pharmaceutical Factory Recent Developments
  127. 6.22 Jiangsu Hansoh Pharmaceutical
  128. 6.22.1 Jiangsu Hansoh Pharmaceutical Company Information
  129. 6.22.2 Jiangsu Hansoh Pharmaceutical Business Overview
  130. 6.22.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  132. 6.22.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  133. 6.23 Sandoz
  134. 6.23.1 Sandoz Company Information
  135. 6.23.2 Sandoz Business Overview
  136. 6.23.3 Sandoz Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Sandoz Pemetrexed Disodium for Injection Product Portfolio
  138. 6.23.5 Sandoz Recent Developments
  139. 6.24 Zhendong Group
  140. 6.24.1 Zhendong Group Company Information
  141. 6.24.2 Zhendong Group Business Overview
  142. 6.24.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
  144. 6.24.5 Zhendong Group Recent Developments
  145. 6.25 Shanghai Chemo Wanbang Biopharma
  146. 6.25.1 Shanghai Chemo Wanbang Biopharma Company Information
  147. 6.25.2 Shanghai Chemo Wanbang Biopharma Business Overview
  148. 6.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
  150. 6.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments
  151. 6.26 Sichuan Huiyu Pharmaceutical
  152. 6.26.1 Sichuan Huiyu Pharmaceutical Company Information
  153. 6.26.2 Sichuan Huiyu Pharmaceutical Business Overview
  154. 6.26.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  156. 6.26.5 Sichuan Huiyu Pharmaceutical Recent Developments
  157. 6.27 Suzhou Erye Pharmaceutical
  158. 6.27.1 Suzhou Erye Pharmaceutical Company Information
  159. 6.27.2 Suzhou Erye Pharmaceutical Business Overview
  160. 6.27.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  162. 6.27.5 Suzhou Erye Pharmaceutical Recent Developments
  163. 6.28 Suzhou Thery Pharmaceutical
  164. 6.28.1 Suzhou Thery Pharmaceutical Company Information
  165. 6.28.2 Suzhou Thery Pharmaceutical Business Overview
  166. 6.28.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  168. 6.28.5 Suzhou Thery Pharmaceutical Recent Developments
  169. 6.29 Jiangsu Simcere Pharmaceutical
  170. 6.29.1 Jiangsu Simcere Pharmaceutical Company Information
  171. 6.29.2 Jiangsu Simcere Pharmaceutical Business Overview
  172. 6.29.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  174. 6.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
  175. 6.30 Yangtze River Pharmaceutical Group
  176. 6.30.1 Yangtze River Pharmaceutical Group Company Information
  177. 6.30.2 Yangtze River Pharmaceutical Group Business Overview
  178. 6.30.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  179. 6.30.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
  180. 6.30.5 Yangtze River Pharmaceutical Group Recent Developments
7 North America by Country
  1. 7.1 North America Pemetrexed Disodium for Injection Sales by Country
  2. 7.1.1 North America Pemetrexed Disodium for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pemetrexed Disodium for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pemetrexed Disodium for Injection Market Size by Country
  6. 7.2.1 North America Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pemetrexed Disodium for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pemetrexed Disodium for Injection Sales by Country
  2. 8.1.1 Europe Pemetrexed Disodium for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pemetrexed Disodium for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pemetrexed Disodium for Injection Market Size by Country
  6. 8.2.1 Europe Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pemetrexed Disodium for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pemetrexed Disodium for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Pemetrexed Disodium for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pemetrexed Disodium for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pemetrexed Disodium for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pemetrexed Disodium for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pemetrexed Disodium for Injection Sales by Country
  2. 10.1.1 South America Pemetrexed Disodium for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pemetrexed Disodium for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pemetrexed Disodium for Injection Market Size by Country
  6. 10.2.1 South America Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pemetrexed Disodium for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pemetrexed Disodium for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Pemetrexed Disodium for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pemetrexed Disodium for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Pemetrexed Disodium for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pemetrexed Disodium for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pemetrexed Disodium for Injection Value Chain Analysis
  2. 12.1.1 Pemetrexed Disodium for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pemetrexed Disodium for Injection Production Mode & Process
  7. 12.2 Pemetrexed Disodium for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pemetrexed Disodium for Injection Distributors
  10. 12.2.3 Pemetrexed Disodium for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst